CJEU for the first time considers the lawfulness (or otherwise) of pay-for-delay patent settlements
Pharmaceutical manufacturers may now find that authorities across Europe increasingly scrutinise patent litigation settlements
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.